world-biotechnology-2016_scientifictracks-abstracts

4 / 22

Notes:
Page 29
World Biotechnology 2016
August 15-17, 2016
Volume 6 Issue 5(Suppl) J Biotechnol Biomater 2016
ISSN: 2155-952X JBTBM, an open access journal
conferenceseries .com
August 15-17, 2016 Sao Paulo, Brazil
Biotechnology World Convention
Ingolf E Blasig, J Biotechnol Biomater 2016, 6:5(Suppl)
Protein-protein and peptide-protein interactions to elucidate protein and cell structures as well as
to modulate pharmacological barriers
Ingolf E Blasig
Leibniz-Institut für Molekulare Pharmakologie, Germany
Pharmacological barriers are formed via extracellular loops (ECLs) of tight junction (TJ) proteins, such as claudins (Cldns).
Thus, Cldn petidomimetics were designed as drug enhancer of the blood-brain barrier (BBB). Cldns, transmembrane
proteins, limit paracellular permeation of pharmaceuticals. The tightening is achieved by protein-protein interaction between
Cldn-ECLs from opposing cells. Consequently, modification of Cldn integrity by the respective peptidomimetics is proposed
to enhance drug delivery through the BBB. The Cldn1 and Cldn5 derived peptides C1C2 and C5C2 were tested for structural,
binding and barrier modulating properties. C1C2 revealed a beta-sheet flanked by an alpha-helix, a structure modeled in the
Cldn1-ECL1 also. C1C2 affected the TJ strand morphology and transiently increased the permeability through a cell culture
model of the BBB. Redistribution of various Cldns from TJs to cytosol suggested interactions with other Cldns subtypes
also. FRET measurements verified heterophilic interactions between different Cldns isoforms. Analysis in TJ-free HEK-
293 cells transfected with Cldn1, -2, -3, -4 or -5 identified Cldn1 and 5 as direct targets. Binding measurements (microscale
thermophoresis) with full-length Cldns and recombinant ECLs confirmed these findings with kd-values in nanomolar range.
Association studies of peptides and recombinant ECLs on live-cells further confirmed the target selectivity. Freeze-fracture
electron microscopy exhibited alterations in the TJ-architecture of Cldn5 by drastic P to E face transition and altered shape of
the Cldn1 TJ-network with enhanced number of parallel strands. C5C2 increased the permeability of a brain endothelial cell
barrier. Transmission electron microscopy showed opening of interendothelial TJs. Binding of C5C2 to Cldn5 showed also
nanomolar affinity. C5C2 administration in mice resulted in concentration and time dependent BBB opening (marker uptake
into brain, magnet resonance imaging). In summary, the Cldn peptidomimetics C1C2 and C5C2 transiently enhanced the
paracellular permeability of Cldn1 and Cldn5 expressing cell barriers by affecting TJ localization and structure. The findings
recommend Cldn peptidomimetics as templates to elucidate molecular and cellular TJ structures and as candidates to improve
drug delivery to the brain.
Biography
Ingolf Blasig studied biology and biochemistry in Leipzig from 1970-74. His diploma thesis was on cancer research at the Robert-Rössle-Hospital in Berlin, his
dissertation dealt with the pharmacology of myocardial infarction at the Academy of Sciences (1984). He obtained his venia legendi for investigations on myocardial
dysfunction at the University of Halle in 19992. From 1993-95, he was awarded project leader at the NIH, USA. Since 1992 he has been head of the independent
research group for Molecular Cell Physiology at the FMP and is teaching at the universities in Potsdam and Berlin.